Aisling Capital related stories
All articles and analysis
Aisling Capital Raises $650 Million for Third FundAisling Capital has closed its third fund with $650 million in capital commitments. The New York-based venture firm focuses on the life sciences and healthcare sectors. It had raised $550 million for its second fund in 2005.
- InsideVenture to feed IPO pipeline
NVCA to organize four roundtable discussions on the IPO market, with one set for this month
- Week in deals, Oct. 27, 2008
News and notes for tech companies and other businesses that raised financing in North America in the past week
- PE Week Wire: Monday, October 27, 2008
Random Ramblings
- PE Week Wire: Monday, October 27, 2008
Random Ramblings
- CeNeRx BioPharma Raises $15 Million
CeNeRx BioPharma Inc., a Cary, N.C.-based developer of CNS drugs, has raised $15 million in Series B funding. Return backers include Aisling Capital, L Capital Partners and Pappas Ventures.
- PE Week Wire: Friday, October 17, 2008
Random Ramblings
- PE Week Wire: Friday, October 17, 2008
Random Ramblings
- PE fund briefs, week of Sept. 15, 2008
Fund-raising news and notes about Lovell Minnick, Darwin Private Equity, Jina Ventures and other private equity firms